Centene Corp is a leading healthcare enterprise that specializes in providing a range of services designed to enhance the quality, accessibility, and affordability of healthcare for individuals and families, particularly those in underserved communities. The company primarily operates within the managed care sector, offering government-sponsored healthcare programs such as Medicaid and Medicare, as well as health insurance marketplace offerings. Centene's commitment to addressing the diverse needs of its members is underscored by its focus on innovative care models, integrated services, and a dedication to improving health outcomes through personalized support and a deep understanding of local health systems. Read More
Curious about the top performers within the S&P500 index one hour before the close of the markets on Friday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Shares of health coverage company Centene (NYSE:CNC)
fell 7.6% in the morning session after the company reported a mixed first-quarter 2025 performance: a decline in total customers and a slightly weaker full-year earnings outlook cast a shadow over the results. On the other hand, revenue and adjusted EPS both beat expectations. Overall, we think this was a weaker quarter.
Curious about the top performers within the S&P500 index in the middle of the day on Friday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Wall Street's three-day rally came to a pause on Friday, with major indices hovering near the flatline by midday in New York as caution returned amid mixed signals on U.S.-China trade relations.
The company now expects the health benefits ratio for the full year to be in the range of 88.9% to 89.5%, up from its previous guidance of 88.4% to 89%.
Health coverage company Centene (NYSE:CNC) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 15.4% year on year to $46.62 billion. The company’s full-year revenue guidance of $180 billion at the midpoint came in 4.2% above analysts’ estimates. Its non-GAAP profit of $2.90 per share was 15.3% above analysts’ consensus estimates.
Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top S&P500 gainers and losers in today's pre-market session.
As the US market prepares to open on Wednesday, let's get an early glimpse into the pre-market session and identify the S&P500 stocks leading the pack in terms of gains and losses.
Stay tuned for the market movements in the S&P500 index on Monday. Check out the gap up and gap down stocks in the S&P500 index during today's session.
Three healthcare stocks have defied trends, rising amid the steep market sell-off. Trump's Medicaid and Medicare comments contributed positively to these names.
President Donald Trump’s sweeping trade tariffs have stoked fears of an all-out trade war and intensified concerns about a global economic recession. While most S&P 500 stocks plunged, a few showed strength. Here is a brief look at 5 such stocks.
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Alignment Healthcare (NASDAQ:ALHC) and the rest of the health insurance providers stocks fared in Q4.
Over the past six months, Centene’s shares (currently trading at $60.25) have posted a disappointing 18.2% loss while the S&P 500 was flat. This may have investors wondering how to approach the situation.
